|
Volumn 255, Issue 12, 2008, Pages 1949-1956
|
Short-latency afferent inhibition predicts verbal memory performance in patients with multiple sclerosis
|
Author keywords
Acetylcholine; Memory; Multiple sclerosis; Short latency afferent inhibition
|
Indexed keywords
ACETYLCHOLINE;
BETA1A INTERFERON;
GLATIRAMER;
METHOTREXATE;
MITOXANTRONE;
RIVASTIGMINE;
ARTICLE;
BRAIN FUNCTION;
CLINICAL ARTICLE;
CLINICAL ASSESSMENT;
COGNITIVE DEFECT;
CONTROLLED STUDY;
DISEASE DURATION;
EVOKED MUSCLE RESPONSE;
EVOKED SOMATOSENSORY RESPONSE;
HUMAN;
MULTIPLE REGRESSION;
MULTIPLE SCLEROSIS;
NEUROPSYCHOLOGICAL TEST;
PATHOGENESIS;
PRIORITY JOURNAL;
PSYCHOLOGIC ASSESSMENT;
SHORT LATENCY AFFERENT INHIBITION;
SINGLE DRUG DOSE;
VERBAL MEMORY;
ADULT;
AFFERENT PATHWAYS;
EVOKED POTENTIALS, MOTOR;
FEMALE;
HUMANS;
MALE;
MEMORY;
MIDDLE AGED;
MULTIPLE SCLEROSIS;
NEURAL INHIBITION;
PREDICTIVE VALUE OF TESTS;
PSYCHOMOTOR PERFORMANCE;
REACTION TIME;
TRANSCRANIAL MAGNETIC STIMULATION;
VERBAL BEHAVIOR;
|
EID: 67349156668
PISSN: 03405354
EISSN: 14321459
Source Type: Journal
DOI: 10.1007/s00415-008-0041-5 Document Type: Article |
Times cited : (18)
|
References (43)
|